PA
ACVA icon

PharVision Advisers’s ACV Auctions ACVA Stock Holding History

PharVision Advisers’s Portfolio ACVA Stock Details ACVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,579
Closed -$125K – 63
2026
Q1 		$125K Buy
+29,579
New +$194K 1.27% 29
2025
Q4 		– Sell
-13,967
Closed -$138K – 672
2025
Q3 		$138K Buy
+13,967
New +$179K 0.08% 582

Other funds holding ACVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's ACVA Position: Q2 2026 in Review

PharVision Advisers sold out of ACV Auctions (ACVA) in Q2 2026, closing a stake of 29,579 shares — an estimated $125K sold.

PharVision Advisers first reported a position in ACVA in Q3 2025 and held it in 2 quarters. The position peaked at $138K in Q3 2025. 258 funds tracked by Wall St. Rank hold ACVA as of Q2 2026.

  • PharVision Advisers reported no remaining ACV Auctions position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 29,579 ACV Auctions shares in Q2 2026, an estimated $125K.
  • PharVision Advisers first reported a position in ACV Auctions in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's ACV Auctions position peaked at $138K in Q3 2025.
  • 258 funds tracked by Wall St. Rank held ACV Auctions as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.